Human myoblast transplantation: Preliminary results of 4 cases
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Myoblasts from immunocompatible donors have been transplanted into the muscles (tibialis anterior, biceps brachii, and/or extensor carpi radialis longus) of 4 Duchenne patients in the advanced stages of the disease. Although no immunosuppressive treatment was used, none of the patients showed any clinical signs of rejection such as fever, redness, and inflammation. One patient transiently produced antibodies against the donor myoblasts as determined by cytofluorometric analysis. This patient and 2 others were shown to form antibodies against their donor's myotubes. Muscle biopsies of the injected tibialis anterior of 4 patients revealed that 80%, 75%, 25% and 0% of the muscle fibers, respectively, showed some degree of dystrophin immunostaining, The contralateral noninjectd muscles of the latter 3 patients did not contain any dystrophin positive fibers, while that of the first patient showed dystrophin expression in 16% of the fibers examined. Myoblasts were also injected into the extensor carpi radialis longus or the biceps brachii of these patients. A few months subsequent to injection, one patient was shown to have a 143% increase of strength during static wrist extension. This result must be interpreted with caution because a double‐blind strength‐measuring protocol was not used. Furthermore, we have noted that this change slowly decayed over time. The strength of 2 other patients was increased less remarkably (41% and 51%), while the strength of the fourth patient was unchanged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification
Chamberlain, J. S., Gibbs, R. A., Rainer, J. E., Nguyen, P. N., & Thomas, C. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.11141 · Cited by 1,262
Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene
Monaco, A. P., Neve, R. L., Colletti-Feener, C., Bertelson, C. J., Kurnit, D. M., & Kunkel, L. M. (1986) · Nature · doi:10.1038/323646a0 · Cited by 1,067
Sex chromatin and gene action in the mammalian X-chromosome.
Lyon, M. F. (1962) · PubMed Central · Cited by 1,009
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction
Beggs, A., Koenig, M., Boyce, F., & Kunkel, L. (1990) · Human Genetics · doi:10.1007/bf00205170 · Cited by 688
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle
Zubrzycka-Gaarn, E. E., Bulman, D. E., Karpati, G., Burghes, A. H. M., Belfall, B., Klamut, H. J., Talbot, J., Hodges, R. S., Ray, P. N., & Worton, R. G. (1988) · Nature · doi:10.1038/333466a0 · Cited by 658
X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALS
LYON, M. F. (1972) · Biological Reviews · doi:10.1111/j.1469-185x.1972.tb00969.x · Cited by 654
Cited by
Identification of a novel population of muscle stem cells in mice
Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., Mytinger, J., Cao, B., Gates, C., Wernig, A., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108150 · Cited by 846
Self-citationSatellite Cells and Skeletal Muscle Regeneration
Dumont, N. A., Bentzinger, C. F., Sincennes, M., & Rudnicki, M. A. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140068 · Cited by 719
“Moreover, the engraftment potential of in vitro cultured myoblasts is very low and the surviving myoblasts rapidly fuse to the fibers and show no long-term engraftment into the stem cell compartment (136).”
Clonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing
Lee, J. Y., Qu-Petersen, Z., Cao, B., Kimura, S., Jankowski, R., Cummins, J., Usas, A., Gates, C., Robbins, P., Wernig, A., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1085 · Cited by 642
Self-citationStem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy
Péault, B., Rudnicki, M., Torrente, Y., Cossu, G., Tremblay, J. P., Partridge, T., Gussoni, E., Kunkel, L. M., & Huard, J. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300145 · Cited by 576
Self-citationMyoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
Mendell, J. R., Kissel, J. T., Amato, A. A., King, W., Signore, L., Prior, T. W., Sahenk, Z., Benson, S., McAndrew, P. E., Rice, R., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331303 · Cited by 534
Sicari, B. M., Rubin, J. P., Dearth, C. L., Wolf, M. T., Ambrosio, F., Boninger, M., Turner, N. J., Weber, D. J., Simpson, T. W., Wyse, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008085 · Cited by 491
Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy
Qu, Z., Balkir, L., van Deutekom, J. C. T., Robbins, P. D., Pruchnic, R., & Huard, J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.5.1257 · Cited by 462
Self-citationEfficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Coutont, D., Cartaud, J., Briand, P., Kaplant, J.-C., Perricaude, M., et al. (1993) · Nature · doi:10.1038/361647a0 · Cited by 457
Tremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., & Richards, C. L. (1993) · Cell Transplantation · doi:10.1177/096368979300200203 · Cited by 345
Self-citationGharaibeh, B., Lu, A., Tebbets, J., Zheng, B., Feduska, J., Crisan, M., Péault, B., Cummins, J., & Huard, J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.142 · Cited by 335
Self-citationThe fate of individual myoblasts after transplantation into muscles of DMD patients
Gussoni, E., Blau, H. M., & Kunkel, L. M. (1997) · Nature Medicine · doi:10.1038/nm0997-970 · Cited by 330
Myoblast transfer in duchenne muscular dystrophy
Karpati, G., Ajdukovic, D., Arnold, D., Gledhill, R. B., Guttmann, R., Holland, P., Koch, P. A., Shoubridge, E., Spence, D., Vanasse, M., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410340105 · Cited by 309
Use of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
Self-citationRapid death of injected myoblasts in myoblast transfer therapy
Fan, Y., Maley, M., Beilharz, M., & Grounds, M. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199607)19:7<853::aid-mus7>3.0.co;2-8 · Cited by 269
Dziki, J., Badylak, S., Yabroudi, M., Sicari, B., Ambrosio, F., Stearns, K., Turner, N., Wyse, A., Boninger, M. L., Brown, E. H. P., et al. (2016) · npj Regenerative Medicine · doi:10.1038/npjregenmed.2016.8 · Cited by 219
The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy
Mouly, V., Aamiri, A., Bigot, A., Cooper, R. N., Di Donna, S., Furling, D., Gidaro, T., Jacquemin, V., Mamchaoui, K., Negroni, E., et al. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01417.x · Cited by 106
Myoblast-mediated gene transfer to the joint
Day, C. S., Kasemkijwattana, C., Menetrey, J., Floyd, S. S., Booth, D., Moreland, M. S., Fu, F. H., & Huard, J. (1997) · Journal of Orthopaedic Research · doi:10.1002/jor.1100150616 · Cited by 66
Self-citation
Metadata
- Authors
- Huard, J., Bouchard, J. P., Roy, R., Malouin, F., Dansereau, G., Labrecque, C., Albert, N., Richards, C. L., Lemieux, B., & Tremblay, J. P.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 1992-05
- Volume
- 15
- Issue
- 5
- Pages
- 550-560
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2124791711
- Cited by
- 253
- References
- 33
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.